CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1967; 17:209-212
doi: 10.3322/canjclin.17.5.209
© 1967 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caldwell, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caldwell, W. L.

CA: A Cancer Journal for Clinicians, Vol 17, 209-212, Copyright © 1967 by American Cancer Society

Treatment of Testicular Tumors

William L. Caldwell M.D.1

1 Director, Division of Radiotherapy and Radiation Research, Vanderbilt University Hospital, Nashville, Tennessee.

Orchiectomy followed by irradiation (3,000-3,500 rads/3-4 weeks) of at least the homolateral pelvis and paraortic lymph nodes is the treatment of choice for Stage I and Stage II seminomas of the testis. Elective irradiation of the mediastinum and supraclavicular regions as well may prove fruitful. Localized nonseminomatous germinal tumors of the testis perhaps are best managed by the same method except with higher doses of irradiation (5,000-5,500 rads/5-6 weeks). The value of radical retroperitoneal lymphadenectomy is yet to be confirmed. It may be advantageous if combined with preoperative and postoperative irradiation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1967 by American Cancer Society.